Medicinal eyewear and optical devices

2:

• The eyewear device of claim 1, wherein the passive light conversion material comprises quantum dots.

3:

• The eyewear device of claim 1, wherein the passive light conversion material comprises organic dyes.

4:

• The eyewear device of claim 1, further comprising at least one optical element configured to direct the PBM light toward the user's eye,
• wherein the optical element includes at least one of micro-optics or a waveguide structure attached to or embedded within the eyewear device.

5:

• The eyewear device of claim 1, wherein at least 25% of the PBM light emitted is at least one of:
• a. approximately 670 nm±50 nm in wavelength and directed towards the user's retina, or
• b. approximately 830 nm±50 nm in wavelength and directed towards the user's periocular skin.

6:

• The eyewear device of claim 1, wherein the lens maintains more visual transparency in a central viewing zone.

7:

• The eyewear device of claim 1, wherein the ambient wavelengths of light being converted are within a range of 320 nm to 700 nm.

8:

• The eyewear device of claim 1 configured to be an augmented reality eyewear device.

9:

• The eyewear device of claim 1 being configured to be at least one of sunglasses, reading glasses, prescription glasses, a contact lens or a face shield.

11:

• The device of claim 10, wherein the optical element is configured to be formed in at least one of a linear-shape, a crescent-shape or a circular shape.

12:

• The device of claim 10, wherein the passive light conversion material comprises at least one of rare-earth phosphors, quantum-dots or dye.

13:

• The device of claim 10, wherein the optical element is configured to adhere to an interior or exterior surface of an eyewear device.

14:

• The device of claim 10, wherein the optical element is configured to enhance PBM light delivery through user's eyewear lens magnification.

15:

• The device of claim 10, wherein the device is detachable and repositionable.

16:

• The device of claim 10, wherein the optical element is configured to comprise at least one of micro-optics or a waveguide structure that directs the PBM light.

17:

• The device of claim 10, wherein the optical element is configured to comprise at least one of micro-optics or a waveguide structure that magnifies and focuses the PBM light.

18:

• The device of claim 10, wherein the device is flexible.

19:

• The device of claim 10, wherein the device is configured to attach to a communication device comprising a video display.

20:

• The device of claim 10 being configured to be attached to at least one of sunglasses, reading glasses, prescription glasses, a transportation vehicle window, a sun visor, a face shield or a hat.

21:

• The device of claim 10, wherein the optical element is configured to enhance PBM light delivery through user's eyewear lens magnification.

22:

• The device of claim 10, wherein the ambient wavelengths of light being converted are within a range of 320 nm to 700 nm.

24:

• The device of claim 23, wherein the first therapeutic wavelength of PBM light is approximately 670 nm and the second therapeutic wavelength of PBM light is approximately 830 nm.

25:

• The device of claim 23, wherein the second therapeutic wavelength of PBM light is between 590 nm and 630 nm.

26:

• The device of claim 23, wherein the at least one of the first or second conversion material is located on a frame portion of the eyewear device.

27:

• The device of claim 23, wherein optical components of the eyewear device are configured to isolate directional light delivery to distinct anatomical zones.

29:

• The device of claim 28, wherein the dermal therapeutic wavelength is selected from at least one of 590 nm, 620 nm, or 830 nm.

30:

• The device of claim 28, wherein the passive light conversion material is integrated into the eyewear arm, corner, or exterior edge of the eyewear device lens.